Teva Pharmaceutical Industries Ltd (TEVA) is higher by Tuesday morning, with the stock rising 0.30% in pre-market trading to 9.91. TEVA's short-term technical score of 55 indicates that the stock has traded more bullishly over the last month than 55% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 129 out of 146 industries, TEVA ranks higher than 71% of stocks. Teva Pharmaceutical Industries Ltd has risen 21.67% over the past month, closing at $8.58 on October 31. During this period of time, the stock fell as low as $8.58 and as high as $10.07. TEVA has an average analyst recommendation of Sell. The company has an average price target of $10.71.
TEVA has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on TEVA!